Literature DB >> 32208001

The kinetics of glucagon action on the liver during insulin-induced hypoglycemia.

Christina Pedersen1, Guillaume Kraft2, Dale S Edgerton2, Melanie Scott2, Ben Farmer2, Marta Smith2, David C Laneve3, Phillip E Williams3, L Merkle Moore2, Alan D Cherrington2.   

Abstract

Glucagon's effect on hepatic glucose production (HGP), under hyperglycemic conditions, is time dependent such that after an initial burst of HGP, it slowly wanes. It is not known whether this is also the case under hypoglycemic conditions, where an increase in HGP is essential. This question was addressed using adrenalectomized dogs to avoid the confounding effects of other counterregulatory hormones. During the study, infusions of epinephrine and cortisol were given to maintain basal levels. Somatostatin and insulin (800 µU·kg-1·min-1) were infused to induce hypoglycemia. After 30 min, glucagon was infused at a basal rate (1 ng·kg-1·min-1, baGGN group, n = 5 dogs) or a rate eightfold basal (8 ng·kg-1·min-1, hiGGN group, n = 5 dogs) for 4 h. Glucose was infused to match the arterial glucose levels between groups (≈50 mg/dL). Our data showed that glucagon has a biphasic effect on the liver despite hypoglycemia. Hyperglucagonemia stimulated a rapid, transient peak in HGP (4-fold basal production) over ~60 min, which was followed by a slow reduction in HGP to a rate 1.5-fold basal. During the last 2 h of the experiment, hiGGN stimulated glucose production at a rate fivefold greater than baGGN (2.5 vs. 0.5 mg·kg-1·min-1, respectively), indicating a sustained effect of the hormone. Of note, the hypoglycemia-induced rises in norepinephrine and glycerol were smaller in hiGGN compared with the baGGN group despite identical hypoglycemia. This finding suggests that there is reciprocity between glucagon and the sympathetic nervous system such that when glucagon is increased, the sympathetic nervous response to hypoglycemia is downregulated.

Entities:  

Keywords:  glucagon; hypoglycemia

Mesh:

Substances:

Year:  2020        PMID: 32208001      PMCID: PMC7272728          DOI: 10.1152/ajpendo.00466.2019

Source DB:  PubMed          Journal:  Am J Physiol Endocrinol Metab        ISSN: 0193-1849            Impact factor:   4.310


  55 in total

Review 1.  Characteristics and hormonal regulation of amino acid transport system A in isolated rat hepatocytes.

Authors:  M S Kilberg; E F Barber; M E Handlogten
Journal:  Curr Top Cell Regul       Date:  1985

2.  Effects of insulin deficiency or excess on hepatic gluconeogenic flux during glycogenolytic inhibition in the conscious dog.

Authors:  Dale S Edgerton; Sylvain Cardin; Catherine Pan; Doss Neal; Ben Farmer; Margaret Converse; Alan D Cherrington
Journal:  Diabetes       Date:  2002-11       Impact factor: 9.461

3.  Hepatic glycogen can regulate hypoglycemic counterregulation via a liver-brain axis.

Authors:  Jason J Winnick; Guillaume Kraft; Justin M Gregory; Dale S Edgerton; Phillip Williams; Ian A Hajizadeh; Maahum Z Kamal; Marta Smith; Ben Farmer; Melanie Scott; Doss Neal; E Patrick Donahue; Eric Allen; Alan D Cherrington
Journal:  J Clin Invest       Date:  2016-05-03       Impact factor: 14.808

4.  Hormonal regulation of amino acid transport in isolated rat hepatocytes: properties of a high affinity transport component induced by glucagon and cyclic AMP.

Authors:  M Fehlmann; P Freychet
Journal:  Adv Cyclic Nucleotide Res       Date:  1981

5.  Insulin-induced hypoglycemia increases hepatic sensitivity to glucagon in dogs.

Authors:  Noelia Rivera; Christopher J Ramnanan; Zhibo An; Tiffany Farmer; Marta Smith; Ben Farmer; Jose M Irimia; Wanda Snead; Margaret Lautz; Peter J Roach; Alan D Cherrington
Journal:  J Clin Invest       Date:  2010-11-15       Impact factor: 14.808

6.  Regulation of urea synthesis by glucose and glucagon in normal man.

Authors:  O Hamberg; H Vilstrup
Journal:  Clin Nutr       Date:  1994-06       Impact factor: 7.324

7.  Transient stimulatory effect of sustained hyperglucagonemia on splanchnic glucose production in normal and diabetic man.

Authors:  J D Bomboy; S B Lewis; W W Lacy; B C Sinclair-Smith; J E Liljenquist
Journal:  Diabetes       Date:  1977-03       Impact factor: 9.461

8.  The role of glucagon in the control of protein and amino acid metabolism in vivo.

Authors:  P J Flakoll; M J Borel; L S Wentzel; P E Williams; D B Lacy; N N Abumrad
Journal:  Metabolism       Date:  1994-12       Impact factor: 8.694

9.  Hypothalamic glucagon signaling inhibits hepatic glucose production.

Authors:  Patricia I Mighiu; Jessica T Y Yue; Beatrice M Filippi; Mona A Abraham; Madhu Chari; Carol K L Lam; Clair S Yang; Nikita R Christian; Maureen J Charron; Tony K T Lam
Journal:  Nat Med       Date:  2013-05-19       Impact factor: 53.440

10.  Counterregulation by epinephrine and glucagon during insulin-induced hypoglycemia in the conscious dog.

Authors:  C C Connolly; R E Ivy; B A Adkins-Marshall; R L Dobbins; D W Neal; P E Williams; A D Cherrington
Journal:  Diabetes Res Clin Pract       Date:  1996-03       Impact factor: 5.602

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.